Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Molecular Bacterial Pathogenesis

This article is part of the Research TopicZoonotic Bacterial Pathogens: Infection and Host InteractionView all 8 articles

Brucella melitensis Clinical Isolate Modulates Osteoclast Differentiation to Drive Pathological Bone Destruction in Brucellar Arthritis

Provisionally accepted
Jinlei  ChenJinlei Chen1Zhi  FeijieZhi Feijie2Guanghai  ZhaoGuanghai Zhao1Mengru  SuMengru Su2Junyun  TuoJunyun Tuo2Wei  SongWei Song1Yuefeng  ChuYuefeng Chu3Haihong  ZhangHaihong Zhang1*
  • 1Lanzhou University Second Hospital, Lanzhou, China
  • 2Lanzhou University, Lanzhou, China
  • 3Lanzhou Veterinary Research Institute Chinese Academy of Agricultural Sciences, Lanzhou, China

The final, formatted version of the article will be published soon.

Background: Brucellosis is a widespread zoonosis that is acquired by humans from infected animals. Articular complications, particularly brucellar spondylitis, are the most prevalent and disabling manifestations of human brucellosis. Inflammation-mediated osteoclast activation is implicated in Brucella-induced bone destruction, but the direct cellular tropism of Brucella within bone tissue and the specific effects of infection on osteoclasts remain poorly understood. This study aims to characterize the osteoclast tropism of Brucella melitensis biovar 3 clinical isolates and their direct regulatory effects on osteoclast-mediated bone destruction in Brucella-induced arthritis. Methods: Brucella clinical isolates were obtained from the bone tissues of human brucellar spondylitis patients in Gansu Province, China. Whole-genome sequencing and biotyping identified their specific biovars. These isolates were used to generate arthritis in immunodeficient NCG mice; bone homeostasis in these mice was assessed via ELISA. We assessed their cellular tropism and osteoclast-modulating effects through intracellular survival assays, immunofluorescence, histopathology, TRAP staining, and resorption pit analysis. Results: Three clinical isolates of B. melitensis biovar 3 were obtained from arthritis lesions in patients from Gansu. Genomic analysis revealed homology with geographically diverse Chinese Brucella strains. Although these isolates reached splenic bacterial loads similar to the virulent strain 16M, they did not cause splenomegaly by two weeks post-infection. The isolates displayed strong tropism for human and murine osteoclasts, achieving significantly higher intracellular loads compared to osteoblasts or osteocytes. Infection at the osteoclast precursor/bone marrow macrophage stage enhanced early osteoclastogenesis while inhibiting late-stage apoptosis and fusion, leading to prolonged osteoclast survival and aggravated bone resorption and defects. In contrast, conditioned medium from infected osteoblasts or osteocytes had minimal impact on late-stage osteoclast differentiation.

Keywords: B. melitensis biovar 3, Bone Resorption, Brucellar arthritis, Osteoclast differentiation and function, pathological bone destruction

Received: 28 Aug 2025; Accepted: 28 Nov 2025.

Copyright: © 2025 Chen, Feijie, Zhao, Su, Tuo, Song, Chu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Haihong Zhang

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.